FDA Drug Safety Communication: Bisphosphonates and Esophageal Cancer
The U.S. Food and Drug Administration (FDA) is continuing to review data from published studies to evaluate whether use of oral bisphosphonate drugs is associated with an increased risk of cancer of the esophagus (esophageal cancer).
Common Osteoporosis Drugs Linked to Increased Cancer Risk
Oral bisphosphonates, a treatment for bone disease, may double the risk of developing esophageal cancer (cancer of the gullet), according to a new study from the University of Oxford.
- (-) Remove Cancer filter Cancer
- (-) Remove Neuromuscular Disease filter Neuromuscular Disease
- (-) Remove Osteoporosis filter Osteoporosis